Cohance Lifesciences P/B Ratio

Current P/B Ratio
4.47
High Valuation
Very High - Significant premium, high growth expectations or speculative

Cohance Lifesciences P/B ratio. Cohance Lifesciences (COHANCE) P/B ratio is 4.47 (High), book value per share ₹1061.58 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Cohance Lifesciences share price screener.

Current Valuation Metrics

P/B Ratio 4.47
Current Price ₹459.45
Book Value/Share ₹1061.58
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹4,034 Cr
Share Capital ₹38 Cr
Reserves & Surplus ₹3,873 Cr
Outstanding Shares 38,000,000
Book Value per Share ₹1061.58

Valuation Signal

Signal Overvalued
Historical Avg 0.83
Historical Range 0.36 - 1.44
Percentile 100.0%

Sector Context

Sector Average -0.3
Sector Median 0.39
Sector Rank #11 of 50
Sector Percentile 22.0%

COHANCE P/B Ratio — Valuation Insights & Book Value Analysis

Cohance Lifesciences price-to-book ratio interpretation, valuation status and historical context — current P/B 4.47 (High). Browse Cohance Lifesciences financial data for revenue, profit, balance sheet and cash flow data.

  • Stock appears overvalued with PB of 4.47, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 438.6% above historical average
  • Trading at premium to sector average PB of -0.3

Cohance Lifesciences P/B Ratio Historical Trend

COHANCE annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read Cohance Lifesciences dividend policy for the complete payout history and dividend yield track record.

COHANCE Historical P/B Ratio — Book Value Per Share & Year-End Price

Cohance Lifesciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 0.43 ₹1061.58 ₹459.45 ₹4,034 Low
2025 0.36 ₹1458.85 ₹528.60 ₹3,793 Low
2024 1.44 ₹788.85 ₹1138.75 ₹2,051 Moderate
2023 1.08 ₹667.31 ₹722.80 ₹1,735 Moderate
2022 0.84 ₹587.31 ₹494.90 ₹1,527 Low

COHANCE vs Healthcare Peers — P/B Ratio Comparison

Cohance Lifesciences P/B 4.47 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.

Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Chennai Meenakshi Multis… CMMHOSP -7.62 ₹27 Low
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹39 Low
Krebs Biochemicals & Ind… KREBSBIO -0.75 ₹128 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹43 Low